TY - JOUR
T1 - Increased risk of renal deterioration associated with low e-GFR in type 2 diabetes mellitus only in albuminuric subjects
AU - Meguro, Shu
AU - Shigihara, Toshikatsu
AU - Kabeya, Yusuke
AU - Tomita, Masuomi
AU - Atsumi, Yoshihito
PY - 2009
Y1 - 2009
N2 - Objective: The significance of estimated glomerular filtration rate (e-GFR) in diabetic nephropathy has yet to be clearly determined. We therefore compared albuminuria and e-GFR for usefulness in predicting progressive decline in renal function. Methods: A total of 1,303 subjects with type 2 diabetes mellitus whose e-GFR was more than 30 mL/min/1.73 m2 were followed for three years. Associations of clinical staging based on AER and that based on e-GFR with progression of renal insufficiency (e-GFR <30 mL/min/1.73 m2) were evaluated. Results: On univariate analysis, both clinical stages based on e-GFR and AER were significant variables (p< 0.05). On multiple logistic regression analysis, the odds ratio for macroalbuminuria was 132.3, and that for microalbuminuria was 10.3 while that for e-GFR less than 60 mL/ min/1.73 m2 was 9.0 for further deterioration of renal function. On the other hand, subjects without albuminuria exhibited a rate of disease progression of less than 1% irrespective of e-GFR level. Conclusions: Both albuminuria and reduced e-GFR are significant and independent risk factors for further deterioration of diabetic nephropathy, though albuminuria had a greater odds ratio than reduced e-GFR for deterioration of renal function over a three-year period, e-GFR exhibited additive risk for deterioration of diabetic nephropathy within three years only when albuminuria was present.
AB - Objective: The significance of estimated glomerular filtration rate (e-GFR) in diabetic nephropathy has yet to be clearly determined. We therefore compared albuminuria and e-GFR for usefulness in predicting progressive decline in renal function. Methods: A total of 1,303 subjects with type 2 diabetes mellitus whose e-GFR was more than 30 mL/min/1.73 m2 were followed for three years. Associations of clinical staging based on AER and that based on e-GFR with progression of renal insufficiency (e-GFR <30 mL/min/1.73 m2) were evaluated. Results: On univariate analysis, both clinical stages based on e-GFR and AER were significant variables (p< 0.05). On multiple logistic regression analysis, the odds ratio for macroalbuminuria was 132.3, and that for microalbuminuria was 10.3 while that for e-GFR less than 60 mL/ min/1.73 m2 was 9.0 for further deterioration of renal function. On the other hand, subjects without albuminuria exhibited a rate of disease progression of less than 1% irrespective of e-GFR level. Conclusions: Both albuminuria and reduced e-GFR are significant and independent risk factors for further deterioration of diabetic nephropathy, though albuminuria had a greater odds ratio than reduced e-GFR for deterioration of renal function over a three-year period, e-GFR exhibited additive risk for deterioration of diabetic nephropathy within three years only when albuminuria was present.
KW - Albuminuria
KW - Chronic kidney disease
KW - Diabetic nephropathy
KW - Risk factor
UR - http://www.scopus.com/inward/record.url?scp=67650034212&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650034212&partnerID=8YFLogxK
U2 - 10.2169/internalmedicine.48.1865
DO - 10.2169/internalmedicine.48.1865
M3 - Article
C2 - 19420810
AN - SCOPUS:67650034212
SN - 0918-2918
VL - 48
SP - 657
EP - 663
JO - Internal Medicine
JF - Internal Medicine
IS - 9
ER -